Moreover, accelerated disruption of the microvascular architecture with chronic CXCR4 blockade was associated with augmented renal decline and progressive renal fibrosis, analogous to the exacerbation of cardiac dysfunction with chronic CXCR4 blockade in the post-myocardial infarction setting [34]. The gene discussed is CXCR4; the disease is renal fibrosis.